Bromocriptine mesylate: FDA-approved novel treatment for type-2 diabetes (Q33874067)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Bromocriptine mesylate: FDA-approved novel treatment for type-2 diabetes |
scientific article |
Statements
1 reference
Bromocriptine mesylate: FDA-approved novel treatment for type-2 diabetes (English)
1 reference
Rajiv Mahajan
1 reference
1 August 2009
1 reference
1 reference
41
1 reference
197-198
1 reference
Identifiers
1 reference
1 reference
1 reference